Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:41 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 97 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Multiparametric MRI Clear all

Conditions: Prostate Cancer, Adverse Effects Surgery, MRI, Ultrasound, Sexual Function Disturbances, Urinary Incontinence, Urinary Function Disorders, Prostate Biopsy, Ablation
Interventions: TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of Prostate Cancer (TPF-LITT); Device
Lead sponsor: Urological Research Network, LLC; Other
Eligibility: 50 Years to 80 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2033
U.S. locations: 1
States / cities: Hialeah, Florida

Conditions: Health Status Unknown, Prostate Carcinoma
Interventions: 3 Tesla Magnetic Resonance Imaging, Gadodiamide, Multiparametric Magnetic Resonance Imaging, Transrectal Biopsy, Ultrasound-Guided Prostate Biopsy; Procedure · Radiation
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: Male only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Castrate Sensitive Prostate Cancer
Interventions: goserelin, Enzalutamide, Abiraterone, 18F-DCFPyL, Prednisone, Radical Prostatectomy; Drug · Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 99 Years · Male only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Prostate Neoplasm
Interventions: CAT, 18F-FMAU, Laboratory Biomarker Analysis, Multiparametric Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound; Device · Drug · Other + 1 more
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older · Male only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Non-Alcoholic Fatty Liver Disease
Interventions: Liver MultiScan; Device
Lead sponsor: Perspectum; Industry
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Liver Cancer, Hepatocellular Carcinoma, Hepatocellular Cancer, Cholangiocarcinoma, Liver Metastases
Interventions: HepQuant DuO, Multiparametric MRI Scans; Diagnostic Test · Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Prostate Cancer, PI-RADS 3 Prostate Lesion
Interventions: PET Imaging with Flotufolastat F 18; Diagnostic Test
Lead sponsor: SimonMed Imaging; Other
Eligibility: 18 Years and older · Male only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 6
States / cities: Avondale, Arizona • Chandler, Arizona • Mesa, Arizona + 3 more

Conditions: Prostate Cancer, Polygenic Risk Score
Interventions: Polygenic Risk Score (PRS); Other
Lead sponsor: Adam S. Kibel, MD; Other
Eligibility: 40 Years to 69 Years · Male only
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland • Boston, Massachusetts

Conditions: Prostate Cancer
Interventions: Micro-ultrasound targeted biopsy, mpMRI targeted biopsy; Diagnostic Test
Lead sponsor: Exact Imaging; Industry
Eligibility: 40 Years to 75 Years · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Interventions: MRI-Guided Transurethral Ultrasound Ablation, Questionnaire Administration, Digital Rectal Examination, Cystoscopy, Biopsy, Bone Scan, PSMA PET Scan, Multiparametric Magnetic Resonance Imaging; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years to 80 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Transplant, Heart, Magnetic Resonance Imaging
Interventions: MRI Sequencing, MRI Testing (pediatric), MRI Testing; Diagnostic Test
Lead sponsor: Northwestern University; Other
Eligibility: Not listed
Enrollment: 247 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2030
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Autoimmune Hepatitis
Interventions: LiverMultiscan; Device
Lead sponsor: Perspectum; Industry
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Breast Cancer, Stage 0
Interventions: Breast MRI, Laboratory Biomarker Analysis; Diagnostic Test · Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 122 participants
Timeline: 2018 – 2032
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Prostate Adenocarcinoma, Incontinence Stress, Erectile Dysfunction Following Radical Prostatectomy
Interventions: Maximal urethral length preservation technique of robot assisted radical prostatectomy (RALP).; Procedure
Lead sponsor: Larkin Health System; Other
Eligibility: 18 Years and older · Male only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Cannabis, HIV, Inflammation, Cognition, Neuroimaging
Interventions: Multimodal, multi-parametric MRI, Immune and cytokine profiling, Neuropsychological testing; Other · Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 25 Years to 59 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Acute and Progressive, Clinically Isolated Syndrome, CNS Demyelinating
Interventions: Clemastine Fumarate, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 55 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Glioma
Interventions: [18F]FMISO-PET with contrast-enhanced MRI; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Prostate Cancer
Interventions: Genomic Prostate Score assay and Multi-parametric magnetic resonance imaging study of the prostate; Other
Lead sponsor: Northwestern University; Other
Eligibility: 40 Years to 76 Years · Male only
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Brain Tumor, Recurrent, Adult
Interventions: PET/CT with F-Fluciclovine (Axumin); Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Prostate Carcinoma
Interventions: Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol, Magnetic Resonance Imaging, Multiparametric Magnetic Resonance Imaging, Positron Emission Tomography, Transrectal Ultrasonography Guided Biopsy; Drug · Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Glioma
Interventions: Fractionated Radiation, Temozolomide, MRI; Radiation · Drug · Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Prostate Carcinoma
Interventions: Multiparametric Magnetic Resonance Imaging; Diagnostic Test
Lead sponsor: ECOG-ACRIN Cancer Research Group; Network
Eligibility: 18 Years and older · Male only
Enrollment: 852 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 44
States / cities: Phoenix, Arizona • Scottsdale, Arizona • New Haven, Connecticut + 31 more

Conditions: Prostatic Cancer, Prostatic Neoplams, Prostatic Hyperplasia, Prostate Cancer, Cancer Of Prostate
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Male only
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2033
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Prostate Carcinoma
Interventions: Biospecimen Collection, Microwave Ablation, Multiparametric Magnetic Resonance Imaging, Questionnaire Administration, Radical Prostatectomy; Procedure · Device · Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer

Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population

HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer

POSLUMA PET Imaging for PI-RADS 3 Prostate Lesions

Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer

Urology San Antonio MRI/MicroUS Comparison

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

Heart Transplantation - Renewal

AIH Risk Stratification With Multiparametric MRI

MRI Characterization of Mammographically Detected DCIS

A Prospective Study to Evaluate the Impact of Maximal Urethral Length Preservation Technique During Robotic Laparoscopic Prostatectomy on the Stretched Flaccid Penile Length and Continence

Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliomas

MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)

18F-Fluciclovine PET and Multiparametric MR Imaging

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Prostate Resection After Microwave Ablation (PRAMA)